When Lauren’s treatment finished she thought she’d be overjoyed, but instead struggled with anxiety. She explains why she’s campaigning for better Care After Breast Cancer.
Palbociclib (Ibrance) was approved as a first-line treatment for secondary breast cancer, but when will it be made available as a second or later-line treatment?
Stella talks about struggling to feel like herself once treatment ended, how she found support, and why she's campaigning for better care after treatment.